妊娠期糖尿病应用个体化医学营养治疗的干预效果

Intervention Effect of Individualized Medical Nutrition Therapy on Gestational Diabetes

目的对个体化医学营养治疗在妊娠期糖尿病患者中的临床应用效果进行分析,探究其应用价值。方法便利选取2019年10月—2021年2月在该院开展临床治疗的妊娠期糖尿病患者,参与研究对象为70例,借助奇偶数分组方式将研究对象划分为两组,参照组对患者开展的治疗方式为常规营养干预,观察组患者对患者开展的治疗方式为个体化医学营养治疗,对两组患者血糖水平、血脂水平以及妊娠结局予以对比。结果观察组患者HOMA-IR、FBG、2 hPG、TC、HDL-C以及LDL-C治疗后分别为(2.48±0.32)、(4.81±0.28)mmol/L、(5.73±0.89)mmol/L、(4.31±0.25)mmol/L、(1.32±0.28)mmol/L、(2.69±0.25)mmol/L,各项指标均优于参照组,差异有统计学意义(t=9.826、8.032、2.330、14.972、2.149、6.146,P<0.05);同时,观察组患者不良妊娠结局发生率为5.7%,低于参照组的17.1%,差异无统计学意义(χ^(2)=2.040,P=0.153)。结论应用个体化医学营养治疗方式对妊娠期糖尿病患者进行干预,可以对患者血糖与血脂指标予以有效调节,减少患者不良妊娠结局的发生率,为母婴安全提供保障,值得在临床上推荐使用。

Objective To analyze the clinical application effect of individualized medical nutrition therapy in patients with gestational diabetes and explore its application value.Methods From October 2019 to February 2021,conveniently selected 70 patients with gestational diabetes who were undergoing clinical treatment in the hospital participated in the study.The study objects were divided into two groups with the help of odd and even grouping,and the treatment of patients in the reference group was routine nutritional intervention,and the treatment of patients in the observation group was individualized medical nutrition therapy.The blood glucose levels,blood lipid levels and pregnancy outcomes of the two groups were compared.Results The post-treatment data of HOMA-IR,FBG,2 hPG,TC,HDL-C and LDL-C in the observation group were(2.48±0.32),(4.81±0.28)mmol/L,(5.73±0.89)mmol/L,(4.31±0.25)mmol/L,(1.32±0.28)mmol/L,(2.69±0.25)mmol/L,all indicators were better than the reference group,the difference was statistically significant(t=9.826,8.032,2.330,14.972,2.149,6.146,P<0.05);at the same time,the incidence of adverse pregnancy outcomes in the observation group was 5.7%,which was lower than 17.1%in the reference group,but the difference was not statistically significant(χ^(2)=2.040,P=0.153).Conclusion The application of individualized medical nutrition therapy to intervene in patients with gestational diabetes can effectively adjust the blood glucose and blood lipids of the patients,reduce the incidence of adverse pregnancy outcomes in patients,and provide protection for the safety of mothers and infants.It is worth recommending clinically.